CXCL3 and squamous cell carcinoma: In a panel of normal/tumour matched samples, the chemokines and receptors displayed no altered expression pattern between adenocarcinoma and squamous cell carcinoma samples, with the exception of CXCL3 (average value elevated in squamous cell carcinoma and reduced in adenocarcinoma).